<?xml version="1.0" encoding="UTF-8"?>
<p>Namisol
 <sup>®</sup> is a new formulation of a tablet containing purified Δ9-THC (&gt;98%) in fixed dosages with high and predictable bioavailability and beneficial pharmacokinetic and pharmacodynamics characteristics after oral administration [
 <xref rid="B172-molecules-25-04036" ref-type="bibr">172</xref>]. Echo Pharmaceuticals BV has been formulated Namisol
 <sup>®</sup> using a patented drug delivery technology, Alitra™, to improve absorption and distribution of compounds with low water solubility. The Namisol
 <sup>®</sup> was developed to improve abdominal pain resulting from chronic pancreatitis (CP).
</p>
